TD Cowen Initiates Coverage on Tempus AI (NASDAQ:TEM)

Research analysts at TD Cowen began coverage on shares of Tempus AI (NASDAQ:TEMGet Free Report) in a report issued on Tuesday, Marketbeat Ratings reports. The firm set a “buy” rating and a $50.00 price target on the stock. TD Cowen’s price objective suggests a potential upside of 42.86% from the stock’s current price.

TEM has been the topic of several other reports. JPMorgan Chase & Co. began coverage on Tempus AI in a research report on Tuesday. They set an “overweight” rating and a $42.00 price target on the stock. Loop Capital began coverage on Tempus AI in a research report on Tuesday. They set a “buy” rating and a $48.00 price target on the stock. Nine research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $45.63.

Read Our Latest Stock Analysis on Tempus AI

Tempus AI Stock Up 1.4 %

Shares of Tempus AI stock opened at $35.00 on Tuesday. Tempus AI has a one year low of $22.89 and a one year high of $43.88.

Tempus AI Company Profile

(Get Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Featured Stories

Analyst Recommendations for Tempus AI (NASDAQ:TEM)

Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.